NMDA antagonists
Articles tagged with “NMDA antagonists”
Ketamine Side Effects Data: What TRD Patients Need to Know
New clinical analysis urges smarter ketamine protocols for TRD, what side effect data and dropout rates mean for patients exploring online ketamine treatment.
What New NMDA Data Means for Ketamine Patients
New clinical guidance on NMDA receptor antagonists urges smarter dose optimization and faster switching. Here's what it means for online ketamine patients.
NMDA Antagonists for TRD: What the Data Means for You
New clinical data on NMDA receptor antagonists for TRD highlights side effect profiles, dropout rates, and why faster dose optimization matters for patients.
When Clinicians Switch Sooner: New TRD Dosing Guidance
New clinical guidance urges faster dose adjustments and PHQ-9 tracking for ketamine patients. Here's what it means for your online treatment.
What Side Effect Data Means for Ketamine Patients
New research in Psychiatric Times breaks down side effect profiles and dropout rates for ketamine and esketamine. Here's what it means for your treatment decision.
What Ketamine's Side Effect Data Means for You
New clinical guidance on NMDA antagonist side effects and discontinuation rates has direct implications for patients pursuing ketamine therapy online.
New Research on Ketamine Side Effects and What It Means
New clinical data on NMDA antagonist side effects and discontinuation rates reveals what telehealth ketamine patients should expect from accountable providers.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.